Showing 2991-3000 of 10546 results for "".
Levia Introduction
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/levia-introduction-/19428/Levia technology overview, product demonstration and product insights from Lerner Medical Devices team members. Levia®, from Lerner Medical, provides Personal Targeted Phototherapy® for the self-treatment of psoriasis in the privacy and convenience of a patient's home. Levia incorporates easy to usHoya ConBio - Vascular Lesions
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hoya-conbio-vascular-lesions/19454/Vascular Lesions that aren't successfully removed by other treatments are usually successfully removed with the Medlite Laser. Instructions and ideal settings for the laser are discussed.Advocating for HS Patients
https://practicaldermatology.com/series/c-suite-chats/advocating-for-hs-patients/54617/Camille Lee, Head of US Immunology at UCB, discusses how her company has worked to elevate the hidradenitis suppurativa (HS) community and what it means to be patient-centric.Origins of AD: Recent Advances
https://practicaldermatology.com/issues/april-2025/origins-of-ad-recent-advances/35586/This paper reviews a study by Yadev et al. and further investigates the role of transient receptor potential ankyrin 1 (TRPA1) in the pathogenesis of atopic dermatitis (AD).Long-Term Bimzelx Data Presented
https://practicaldermatology.com/series/dermwire-tv/long-term-bimzelx-data-presented/35563/In this week's DermwireTV, new long-term data is presented for Bimzelx (bimekizumab-bkzx) for two indications; an analysis examines the correlation between proximity to tanning facilities and melanoma incidence; and in our C-Suite Chats feature, we hear from the Founder and CEO of Joya Health.New Hope for Patients with Onychomycosis
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/new-hope-for-patients-with-onychomycosis/33161/Onychomycosis, a non-self-healing fungal infection of the toenails or fingernails, is a common infection accounting for 20% of all nail diseases in adults, affecting 5% of the worldwide population.FDA Approves Botox for Vertical Platysma Bands
https://practicaldermatology.com/series/dermwire-tv/fda-approves-botox-vertical-platysma-bands/29127/In this week's DermwireTV, Botox is approved for its fourth aesthetic indication in the US; the FDA clears a new laser for the long-term treatment of patients with acne vulgaris; and the Chief Scientific Officer of Leo Pharma talks about treatment options for chronic hand eczema.Innovations in the Aesthetic Market and Wrinkle Removal Technology
https://practicaldermatology.com/series/c-suite-chats/innovations-aesthetic-market-and-wrinkle-removal-technology/26732/Lou Scafuri, CEO of SofWave Medical, talks about what makes the company’s Synchronous Ultrasound Parallel Beam technology unique.Burnout; Qwo Campaign; Differin, Cetaphil Programs; DermTech Data: DermWireTV
https://practicaldermatology.com/topics/skin-cancer-photoprotection/burnout-qwo-campaign-differin-cetaphil-programs-dermtech-data-dermwiretv/20063/The Dr. Lorna Breen Health Care Provider Protection Act is headed to the president, as the latest Medscape Physician Burnout and Depression Report shows more than half of physicians experiencing burnout say it has a strong or severe impact on their life. Differin marks Retinoid Awareness Week. CetapFive ways to “get real” via marketing and the power of authenticity
https://practicaldermatology.com/topics/practice-management/five-ways-to-get-real-via-marketing-and-the-power-of-authenticity/20058/Let’s get real. Authenticity matters to today’s health care consumers. In this video, Ekwa Marketing (www.ekwa.com) walks dermatology practices through five ways to stand out from the pack. We encourage all providers to consider how the likes of the ingredients they use, the vendors they patronize,